MB

MPM BioImpact Portfolio holdings

AUM $1.29B
1-Year Est. Return 141.72%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+141.72%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$874M
AUM Growth
+$263M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
55
New
Increased
Reduced
Closed

Top Buys

1
+$53.3M
2
+$45.7M
3
+$34.2M
4
CRVS icon
Corvus Pharmaceuticals
CRVS
+$21.6M
5
URGN icon
UroGen Pharma
URGN
+$17.5M

Top Sells

1
+$33.1M
2
+$25.3M
3
+$17.8M
4
ALKS icon
Alkermes
ALKS
+$16.5M
5
VERA icon
Vera Therapeutics
VERA
+$16.4M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CNTX icon
26
Context Therapeutics
CNTX
$262M
$15.7M 1.8%
10,679,391
-4,026,491
ARQT icon
27
Arcutis Biotherapeutics
ARQT
$2.68B
$15.4M 1.77%
+531,200
VTYX
28
DELISTED
Ventyx Biosciences
VTYX
$14.8M 1.69%
+1,639,061
ORIC icon
29
Oric Pharmaceuticals
ORIC
$875M
$14.7M 1.68%
1,798,717
+69,339
BLTE
30
Belite Bio
BLTE
$5.78B
$14M 1.61%
+87,760
RAPT
31
DELISTED
RAPT Therapeutics
RAPT
$13.5M 1.54%
+397,906
CLYM
32
Climb Bio
CLYM
$628M
$10.7M 1.22%
+2,671,480
ABVX
33
Abivax
ABVX
$10.6B
$7.59M 0.87%
+56,316
RCKT icon
34
Rocket Pharmaceuticals
RCKT
$335M
$5.57M 0.64%
1,586,076
-2,317,305
MAZE
35
Maze Therapeutics
MAZE
$1.46B
$3.36M 0.38%
+81,145
EVMN
36
Evommune Inc
EVMN
$837M
$1.93M 0.22%
+113,022
SRPT icon
37
Sarepta Therapeutics
SRPT
$1.89B
$1.51M 0.17%
70,000
-630,000
HOWL icon
38
Werewolf Therapeutics
HOWL
$21.9M
$884K 0.1%
1,393,557
-1,015,253
RAPP
39
Rapport Therapeutics
RAPP
$1.89B
– –
-71,807
ZLAB icon
40
Zai Lab
ZLAB
$1.99B
– –
-745,060
WVE icon
41
Wave Life Sciences
WVE
$1.27B
– –
-1,505,262
VERA icon
42
Vera Therapeutics
VERA
$2.55B
– –
-563,075
SPRY icon
43
ARS Pharmaceuticals
SPRY
$901M
– –
-1,303,399
SLNO
44
DELISTED
Soleno Therapeutics
SLNO
– –
-150,000
SLDB icon
45
Solid Biosciences
SLDB
$723M
– –
-1,634,569
RPTX
46
DELISTED
Repare Therapeutics
RPTX
– –
-819,924
RNAC icon
47
Cartesian Therapeutics
RNAC
$222M
– –
-380,000
RNAM
48
DELISTED
Avidity Biosciences
RNAM
– –
-760,022
RARE icon
49
Ultragenyx Pharmaceutical
RARE
$2.36B
– –
-395,700
JANX icon
50
Janux Therapeutics
JANX
$890M
– –
-614,282
1
2
3